memantine HCl

DRUG6 trials

Sponsors

National Institute of Mental Health (NIMH), Forest Laboratories

Conditions

Alzheimer's DiseaseAutismBipolar DisorderDepressionPediatric AutismSchizophrenia

Phase 2

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

CompletedNCT00097942

Forest LaboratoriesSchizophrenia

Start: 2004-08-31End: 2005-09-30Updated: 2012-03-05

An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder

CompletedNCT00106405

Forest LaboratoriesBipolar Disorder

Start: 2005-02-28End: 2005-11-30Updated: 2012-03-05

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

CompletedNCT01999894

Forest LaboratoriesAutism, Pediatric Autism

Start: 2009-11-30End: 2013-02-28Updated: 2014-03-18

Phase 3

Clinical Trial of Memantine for Major Depression

CompletedNCT00040261

National Institute of Mental Health (NIMH)Depression

Start: 2002-06-30End: 2005-03-31Target: 112Updated: 2008-03-04

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

CompletedNCT00097916

Forest LaboratoriesAlzheimer's Disease

Start: 2004-09-30End: 2006-04-30Updated: 2012-03-05

Phase 4

Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)

CompletedNCT00334906

Forest LaboratoriesAlzheimer's Disease

Start: 2005-07-31Target: 75Updated: 2008-01-07